Business Daily from THE HINDU group of publications
Friday, Jan 04, 2008
ePaper | Mobile/PDA Version


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Preferential Allotments
Pharmaids Pharma warrant issue

Chennai, Jan. 3

Pharmaids Pharmaceuticals Ltd has informed the BSE that a meeting of the board of directors of the company will be held on January 11 to consider the further issue of capital by way of issue of equity shares or warrants on preferential basis to persons/entities as the board may deem fit. —

Our Bureau

More Stories on : Preferential Allotments | Medical & Surgical Equipments

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Asian Electronics to raise Rs 300 cr


Pharmaids Pharma warrant issue
Valecha Engg pref issue
Prime Securities pref issue
Batliboi plans QIP issue
Nokia Siemens bags Airtel contract
PGCIL bags MoU award for '06-07
Soaring crude: IOC may sell Rs 2,000-cr bonds
SEBI for simple primary debt issue process
Nod for recast of farms corpn
Tatas move closer to driving Ford’s Jaguar, Land Rover
‘Ford, Tatas must focus on job, plant security’
Analysts divided over impact
Fresh boost for Tata group in UK with Ford deal
Alembic acquires Nirayu’s unit
Govt in favour of merging Neelachal Ispat with RINL
Asipac asked to prepare design for resort-cum-IT park in Brazil
Jindal Steel pact with Bolivia becomes effective
SAIL, Tata Steel in 50:50 pact to mine coal blocks
Speciality Papers mulls bonus issue
Hyundai hopes alternate fuel models to boost sales
GVK may soon commission Jegurupadu phase II, Gauthami
Indo Asian Fusegear to double switchgear capacity
‘Uptrend in Land Rover, Jaguar sales’


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line